These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 2563294

  • 1. CGS 20625, a novel pyrazolopyridine anxiolytic.
    Williams M, Bennett DA, Loo PS, Braunwalder AF, Amrick CL, Wilson DE, Thompson TN, Schmutz M, Yokoyoma N, Wasley JW.
    J Pharmacol Exp Ther; 1989 Jan; 248(1):89-96. PubMed ID: 2563294
    [Abstract] [Full Text] [Related]

  • 2. CGS 9896: agonist-antagonist benzodiazepine receptor activity revealed by anxiolytic, anticonvulsant and muscle relaxation assessment in rodents.
    Bernard PS, Bennett DA, Pastor G, Yokoyama N, Liebman JM.
    J Pharmacol Exp Ther; 1985 Oct; 235(1):98-105. PubMed ID: 2995650
    [Abstract] [Full Text] [Related]

  • 3. RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent.
    Doble A, Canton T, Dreisler S, Piot O, Boireau A, Stutzmann JM, Bardone MC, Rataud J, Roux M, Roussel G.
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1213-26. PubMed ID: 8103792
    [Abstract] [Full Text] [Related]

  • 4. Differential diazepam-antagonist effects of the benzodiazepine receptor ligand CGS 9895 in rodents.
    Katzman NJ, Shannon HE.
    J Pharmacol Exp Ther; 1985 Dec; 235(3):589-95. PubMed ID: 3001268
    [Abstract] [Full Text] [Related]

  • 5. The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
    Popik P, Kostakis E, Krawczyk M, Nowak G, Szewczyk B, Krieter P, Chen Z, Russek SJ, Gibbs TT, Farb DH, Skolnick P, Lippa AS, Basile AS.
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1244-52. PubMed ID: 16971504
    [Abstract] [Full Text] [Related]

  • 6. Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors.
    Bennett DA, Bernard PS, Amrick CL, Wilson DE, Liebman JM, Hutchison AJ.
    J Pharmacol Exp Ther; 1989 Aug; 250(2):454-60. PubMed ID: 2547931
    [Abstract] [Full Text] [Related]

  • 7. CGS 20625, a novel pyrazolopyridine with selective anxiolytic activity.
    Jarvis MF, Bennett DA, Loo PA, Braunwalder AF, Thompson TN, Schmutz M, Yokoyoma N, Wasley JW, Williams M.
    Prog Clin Biol Res; 1990 Aug; 361():477-82. PubMed ID: 1981266
    [No Abstract] [Full Text] [Related]

  • 8. SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors.
    Griebel G, Perrault G, Simiand J, Cohen C, Granger P, Decobert M, Françon D, Avenet P, Depoortere H, Tan S, Oblin A, Schoemaker H, Evanno Y, Sevrin M, George P, Scatton B.
    J Pharmacol Exp Ther; 2001 Aug; 298(2):753-68. PubMed ID: 11454940
    [Abstract] [Full Text] [Related]

  • 9. Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: neuropharmacological profile of a potential anxiolytic.
    Jenck F, Moreau JL, Bonetti EP, Martin JR, Haefely WE.
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1121-7. PubMed ID: 1356150
    [Abstract] [Full Text] [Related]

  • 10. CGS 8216: agonist and diazepam-antagonist effects in rodents.
    Shannon HE, Katzman NJ.
    J Pharmacol Exp Ther; 1986 Oct; 239(1):166-73. PubMed ID: 3093670
    [Abstract] [Full Text] [Related]

  • 11. Anxiolytic-like effects of the corticotropin-releasing factor1 (CRF1) antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] administered acutely or chronically at doses occupying central CRF1 receptors in rats.
    Lelas S, Wong H, Li YW, Heman KL, Ward KA, Zeller KL, Sieracki KK, Polino JL, Godonis HE, Ren SX, Yan XX, Arneric SP, Robertson DW, Hartig PR, Grossman S, Trainor GL, Taub RA, Zaczek R, Gilligan PJ, McElroy JF.
    J Pharmacol Exp Ther; 2004 Apr; 309(1):293-302. PubMed ID: 14742750
    [Abstract] [Full Text] [Related]

  • 12. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
    Harada K, Aota M, Inoue T, Matsuda R, Mihara T, Yamaji T, Ishibashi K, Matsuoka N.
    Eur J Pharmacol; 2006 Dec 28; 553(1-3):171-84. PubMed ID: 17074317
    [Abstract] [Full Text] [Related]

  • 13. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
    Depoortere H, Zivkovic B, Lloyd KG, Sanger DJ, Perrault G, Langer SZ, Bartholini G.
    J Pharmacol Exp Ther; 1986 May 28; 237(2):649-58. PubMed ID: 2871178
    [Abstract] [Full Text] [Related]

  • 14. 5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic.
    Dubinsky B, Vaidya AH, Rosenthal DI, Hochman C, Crooke JJ, DeLuca S, DeVine A, Cheo-Isaacs CT, Carter AR, Jordan AD, Reitz AB, Shank RP.
    J Pharmacol Exp Ther; 2002 Nov 28; 303(2):777-90. PubMed ID: 12388665
    [Abstract] [Full Text] [Related]

  • 15. Imidazenil: a new partial positive allosteric modulator of gamma-aminobutyric acid (GABA) action at GABAA receptors.
    Giusti P, Ducić I, Puia G, Arban R, Walser A, Guidotti A, Costa E.
    J Pharmacol Exp Ther; 1993 Aug 28; 266(2):1018-28. PubMed ID: 8394902
    [Abstract] [Full Text] [Related]

  • 16. Home cage pretreatment with diazepam: effects on subsequent conflict testing and rotorod assessment.
    Bennett DA, Amrick CL.
    J Pharmacol Exp Ther; 1987 Aug 28; 242(2):595-9. PubMed ID: 3612553
    [Abstract] [Full Text] [Related]

  • 17. Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities. I. Psychopharmacological profile in rodents.
    Keane PE, Simiand J, Morre M, Biziere K.
    J Pharmacol Exp Ther; 1988 May 28; 245(2):692-8. PubMed ID: 2896794
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics, anticonvulsant efficacy and adverse effects of the beta-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs.
    Löscher W, Hönack D, Scherkl R, Hashem A, Frey HH.
    J Pharmacol Exp Ther; 1990 Nov 28; 255(2):541-8. PubMed ID: 1978730
    [Abstract] [Full Text] [Related]

  • 19. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
    Decker MW, Brioni JD, Sullivan JP, Buckley MJ, Radek RJ, Raszkiewicz JL, Kang CH, Kim DJ, Giardina WJ, Wasicak JT.
    J Pharmacol Exp Ther; 1994 Jul 28; 270(1):319-28. PubMed ID: 7913497
    [Abstract] [Full Text] [Related]

  • 20. Pharmacology of the pyrazolo-type compounds: agonist, antagonist and inverse agonist actions.
    Bennett DA.
    Physiol Behav; 1987 Jul 28; 41(3):241-5. PubMed ID: 2893398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.